MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future

The sirtuin family in health and disease

Effect of murine double‐minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys

Putative tumor suppression function of SIRT6 in endometrial cancer